Research shows Nanoform method speeds up absorption and improves drug delivery

These results pave the way for improving absorption and increasing drug load while enabling simpler formulations to maximise patient benefit

picture of

Breaking News

IQVIA discusses supply chain resilience for CPhI Discover

Informa’s CPhI Discover virtual event is taking place from 17-28th May, and the company recently spoke with Aurelio ...

Fareva completes high potency drug investment

The program started in 2016 at the site of Fareva La Vallée

Cardinal Health and FourKites partner on cognitive supply chain

FourKites’ work with Cardinal Health began during the onset of the COVID-19 pandemic with a pilot programme

The supply chain forum: four pillars of capsule-based dry powder inhaler (cDPI) optimisation (part I)

Affordable and patient-centric, capsule-based dry powder inhaler (cDPI) combinations are providing the flexibility ...

Thermo Fisher and Artificial work to enhance COVID-19 testing platform

As part of the partnership, Thermo Fisher will provide feedback on aLab Suite functionalities and capabilities to ...

CureVac and Rentschler Biopharma ramp up vaccine manufacture

The companies aim to produce more than 100 million doses of the CureVac vaccine per year in Laupheim

Using ddPCR to accurately quantify AAV viral titre and integrity

Gene therapy is primed to become the next major development in medicine and bring relief to patients living with ...

Eleva secures up to $74m to advance drug candidate

The company also announced the addition of Dr Ralf Smit to its executive board

Vectura earns $11m milestone with Hikma generic launch

The launch of the product follows approval by the US FDA

Capsule oral dosage forms: providing benefits throughout the entire drug product lifecycle

Drug product formulators and manufacturers often choose tablets instead of capsules as a cost-effective dosage form. ...

Manufacturing Chemist Live: A hybrid event

Taking place on 14-15 September, the event will put delegates ahead of the curve in the global pharmaceutical supply ...

Accelerating excipient development for inhalable dosage forms with QbD

Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...

Orgenesis signs joint venture with Cure Therapeutics

The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies

Merck and Artios Pharma announce oncology collaboration

The agreement does not include Artios’s lead programmes, Polθ and ATR inhibitors, for which it will retain all rights